Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Blackpool Teaching Hospital uses Innovative Technology to Reduce MRSA and MSSA

Published: Thursday, November 15, 2012
Last Updated: Thursday, November 15, 2012
Bookmark and Share
Impact of rapid screening programmes which help hospital reduce costs by improving quality of care and driving efficiency to be presented at FIS/HIS 2012 Conference.

Blackpool Teaching Hospital has introduced rapid screening for the superbug MRSA of all emergency admissions patients, and both MRSA and MSSA for surgical patients admitted through A&E, which helps bring clinical & economic benefits.

In 2008, Blackpool Teaching Hospital recognised the need to implement an effective screening system that would minimise the spread of MRSA, and introduced a rapid polymerase chain reaction (PCR) testing method.  Rapid PCR screening enables quick and accurate identification of MRSA in hospital admissions, which is crucial for optimal & timely treatment decisions, isolation reduction and reducing potential cross-transmission or acquisition of these infections.

Blackpool Teaching Hospital carried out an initial 12 month pilot study of screening all emergency patients using the rapid PCR testing method. The results saw the number of MRSA bacteraemia fall dramatically from the pre-study to pilot study period, and demonstrated clinical benefits & economic advantages of using rapid screening techniques.

In August 2010 Blackpool Teaching Hospitals decided to extend the PCR screening programme (as a pilot) to include MSSA for all surgical patients admitted through A&E.  Preliminary data also shows a significant drop in MSSA bacteraemia (Acute and Primary Care) from 2009-10 to 2011-12.

Dr Achyut Guleri, Consultant Microbiologist and Head of Department for Clinical Laboratory Medicine at Blackpool Teaching Hospitals NHS Foundation Trust says: “The rapid PCR screening system enables timely reporting, aides the clinical decision making process and ensures that high standards of patient management are maintained. Reduced healthcare associated infections are associated with significant cost savings that can be re-invested in other areas of healthcare, transforming patient care in the fylde coast”.

The trust has carefully considered the clinical benefits and economic advantages of the programme and extended it beyond the pilot.  Since the introduction of rapid PCR screening, the number of positive MRSA and MSSA infections including bacteraemias at the hospital have continued to decline with associated reduction in the average length of stay.

The impact of the programmes will be presented by Dr Guleri and Mr Kehoe at a symposium held by medical technology company BD at the Federation of Infection Societies & Hospital Infection Society International Conference, 19-21 November 2012, Liverpool. Mr Aidan Kehoe, the then Chief Executive at Blackpool Teaching Hospitals NHS Foundation Trust, has just been appointed as Chief Executive at The Royal Liverpool and Broadgreen University Hospitals NHS Trust.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos